These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 14515712)

  • 1. Risk management.
    Bartoo G
    IEEE Eng Med Biol Mag; 2003; 22(4):166-70, 172. PubMed ID: 14515712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating risk management into the CAPA process.
    Bills E; Tartal J
    Biomed Instrum Technol; 2008; 42(6):466-8. PubMed ID: 19012461
    [No Abstract]   [Full Text] [Related]  

  • 3. How to kick-start your CAPA process.
    Peterson K
    Biomed Instrum Technol; 2005; 39(1):55-9. PubMed ID: 15742850
    [No Abstract]   [Full Text] [Related]  

  • 4. Design controls.
    Bartoo G
    IEEE Eng Med Biol Mag; 2003; 22(2):112-4. PubMed ID: 12733469
    [No Abstract]   [Full Text] [Related]  

  • 5. Effective risk management programmes.
    Donawa M
    Med Device Technol; 2004 May; 15(4):28-30. PubMed ID: 15303561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is in the QSR/GMP?
    Bartoo G;
    IEEE Eng Med Biol Mag; 2004; 23(4):83-5. PubMed ID: 15508391
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA pilot programme in support of global harmonisation.
    Donawa ME
    Med Device Technol; 2003 Nov; 14(9):32-4. PubMed ID: 14682021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing US and European device testing requirements.
    Donawa M
    Med Device Technol; 2008 Sep; 19(5):32, 34-7. PubMed ID: 18947148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IVD directive: late-phase practicalities.
    Johnson P; Walker R
    Med Device Technol; 2003 Nov; 14(9):35-6. PubMed ID: 14682022
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulatory reticence and medical devices.
    Fox DM; Zuckerman DM
    Milbank Q; 2014 Mar; 92(1):151-9. PubMed ID: 24597559
    [No Abstract]   [Full Text] [Related]  

  • 11. Beyond the US submisson process.
    Donawa M
    Med Device Technol; 2004 Apr; 15(3):30-2. PubMed ID: 15255536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. US and European postmarket clinical data requirements.
    Donawa M
    Med Device Technol; 2005 Mar; 16(2):19-21. PubMed ID: 15828495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing a procedure for serious medical device problem reporting.
    Amtower P
    J Healthc Risk Manag; 1993; 13(4):14-21. PubMed ID: 10129557
    [No Abstract]   [Full Text] [Related]  

  • 14. What the code of federal regulations means to you.
    Yellin A
    Biomed Instrum Technol; 2005; 39(4):285-7. PubMed ID: 16111404
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of the revised electromagnetic compatibility standard.
    Bozec D; Hayes DJ
    Med Device Technol; 2004 Oct; 15(8):33-4, 36. PubMed ID: 16225272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of the Medical Device Directive.
    Donawa M
    Med Device Technol; 2003 Mar; 14(2):20-3. PubMed ID: 12698694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk management of European device clinical studies.
    Donawa M
    Med Device Technol; 2007; 18(2):39-42. PubMed ID: 17494500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination products and the role of medical device firms.
    Etheredge R
    Biomed Instrum Technol; 2005; 39(2):143-6. PubMed ID: 15810788
    [No Abstract]   [Full Text] [Related]  

  • 19. Myths and realities in medical packaging.
    Pilchik R
    Med Device Technol; 2003 Mar; 14(2):16-7. PubMed ID: 12698692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European Animal Tissue Directive.
    Donawa M
    Med Device Technol; 2004; 15(1):28-31. PubMed ID: 14994636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.